Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreren
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

TELA BIO, INC.

(TELA)
  Rapport
Vertraagde tijd Nasdaq  -  22:00:00 03-02-2023
11.21 USD   -2.27%
12/01Transcript : TELA Bio, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-12-2023 08:15 AM
CI
09/01TELA Bio kondigt de commerciële lancering van NIVIS Fibrillar Collagen Pack in de VS aan.
CI
2022TELA Bio, Inc. : JMP Securities nog altijd een koopadvies
MM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op TELA BIO, INC.
20/01TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/01TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/01Tela Bio, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
09/01Tela Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
09/01TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The ..
09/01TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The ..
09/01TELA Bio Announces U.S. Commercial Launch of NIVIS Fibrillar Collagen Pack
2022TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference
2022TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference
2022TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635
2022TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2022TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2022TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference
2022Certain Warrants of TELA Bio, Inc. are subject to a Lock-Up Agreement Ending on 14-NOV..
2022Certain Stock Options of TELA Bio, Inc. are subject to a Lock-Up Agreement Ending on 14..
2022Certain Common Stock of TELA Bio, Inc. are subject to a Lock-Up Agreement Ending on 14-..
2022TELA BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
2022Tela Bio, Inc. : Results of Operations and Financial Condition, Regulation FD Disclosure, ..
2022TELA Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep..
2022Earnings Flash (TELA) TELA BIO Posts Q3 Revenue $11.2M
2022Earnings Flash (TELA) TELA BIO Posts Q3 Revenue $11.2M
2022TELA Bio Reports Third Quarter 2022 Financial Results
2022TELA Bio Reports Third Quarter 2022 Financial Results
2022TELA Bio, Inc. Provides Revenue Guidance for the Full Year 2022
2022TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services..
2022TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services..
2022TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2022TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2022TELA Bio to Announce Third Quarter 2022 Financial Results
2022Tela Bio, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
2022TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits o..
2022TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits o..
2022TELA Bio, Inc. Announces Publication of 24-Month Bravo Study Results Demonstrating Bene..
2022TELA Bio, Inc.(NasdaqGM:TELA) dropped from S&P Global BMI Index
2022TELA Bio to Participate in Upcoming Investor Conferences
2022TELA Bio to Participate in Upcoming Investor Conferences
2022TELA Bio to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase
2022TELA Bio to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase
2022TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Unde..
2022TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Unde..
2022Tela Bio, Inc. : Entry into a Material Definitive Agreement, Financial Statements and Exhi..
2022TELA Bio Prices Common Stock Offering at $8 Apiece
2022TELA Bio Announces Pricing of Public Offering of Common Stock
2022TELA Bio Announces Pricing of Public Offering of Common Stock
2022TELA Bio's Q2 Loss Widens, Revenue Rises; Adjusts FY 2022 Revenue Estimate
2022TELA Bio Announces Proposed Public Offering of Common Stock
2022Tela Bio, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
2022TELA BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
2022Tela Bio : Reports Second Quarter 2022 Financial Results - Form 8-K
2022TELA Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Jun..
2022Earnings Flash (TELA) TELA BIO Posts Q2 Revenue $10.4M, vs. Street Est of $10.1M
2022TELA Bio Reports Second Quarter 2022 Financial Results
2022TELA Bio Reports Second Quarter 2022 Financial Results
2022TELA Bio, Inc. Provides Revenue Guidance for the Full Year 2022
2022TELA Bio to Participate in Upcoming Investor Conferences
2022TELA Bio to Participate in Upcoming Investor Conferences
2022TELA Bio Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTexģ Rei..
2022Tela Bio, Inc. Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTe..
2022TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2022TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2022TELA Bio to Announce Second Quarter 2022 Financial Results
2022TELA Bio Secures Group Purchasing Agreement With Premier for Bioabsorbable Products
2022TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc.
2022TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc.
2022TELA Bio, Inc. Wins Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc
2022Top Premarket Gainers
2022Tela Bio, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K)
2022TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference
2022TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference
2022Tela Bio : Material Definitive Agreement - Form 8-K
2022Tela Bio, Inc. : Entry into a Material Definitive Agreement, Termination of a Material Def..
2022TELA Bio Enters Into New $50 Million Credit Facility With MidCap Financial
2022TELA Bio Secures Up to $50 Million in Debt Financing from MidCap Financial
2022TELA Bio Secures Up to $50 Million in Debt Financing from MidCap Financial
2022TELA Bio Secures Up to $50 Million in Debt Financing from MidCap Financial
2022TELA Bio to Participate in Upcoming Jefferies Healthcare Conference
2022TELA Bio, Inc. Provides Revenue Guidance for the Fiscal Year 2022
2022TELA BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
2022Spectrum Pharmaceuticals Names Nora Brennan CFO
2022Earnings Flash (TELA) TELA BIO Posts Q1 Revenue $8.2M, vs. Street Est of $7.95M
2022TELA Bio's Q1 Loss Widens, Revenue Rises; Maintains 2022 Sales Guidance
2022Tela Bio, Inc. : Results of Operations and Financial Condition, Regulation FD Disclosure, ..
2022TELA Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
2022TELA Bio Reports First Quarter 2022 Financial Results
2022TELA Bio Reports First Quarter 2022 Financial Results
2022TELA Bio, Inc. Announces Revenue Guidance for the Full Year 2022
2022TELA Bio to Participate in Upcoming 2022 H.C. Wainwright Annual Global Investment Conf..
2022TELA Bio to Participate in Upcoming 2022 H.C. Wainwright Annual Global Investment Conf..
2022TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2022TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2022TELA Bio to Announce First Quarter 2022 Financial Results
2022TELA Bio Appoints D. Taylor Ocasio as General Counsel
2022TELA Bio, Inc. Appoints Taylor Ocasio as General Counsel
2022TELA Bio to Participate in Upcoming Needham & Co. 21st Annual Healthcare Virtual Confer..
2022TELA Bio to Participate in Upcoming Needham & Co. 21st Annual Healthcare Virtual Confer..
2022TELA BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
2022Tela Bio Posts Wider Q4 Net Loss, Higher Revenue; Warns of Potential Pandemic-Related I..
2022Tela Bio : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K
2022Tela Bio, Inc. : Results of Operations and Financial Condition, Regulation FD Disclosure, ..
2022TELA Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
Volgende evenement op TELA BIO, INC.